mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |